|
|
||||||||
Clinical Chemistry, Vol 25, 2011-2014, Copyright © 1979 by American Association for Clinical Chemistry
JY Tsay, IW Chen, HR Maxon and L Heminger
Determination of normal ranges from laboratory data containing undectable values is a frequently encountered problem in the radioimmunoassay of peptide hormones. In the past, such determinations usually have been based on the mid-point method or the one-end Winsorized method. A graphic method involving the use of probability paper has also been reported. We propose that the maximum-likelihood estimation is a more appropriate statistical method for the determination of normal range from this type of data (Type I censored data). With this method, the mean and standard deviation, and hence the tolerance limits, can be estimated. We used the maximum-likelihood estimation method to determine the normal range of serum thyrotropin values obtained from 93 healthy subjects, based on a log normal distribution. Although the serum thyrotropin content was undetectable in 14% of the subjects, a normal range could be calculated. Using tolerance limits for 95% coverage of the population with 90% confidence, we calculated the normal range of thyrotropin to be 0.51- 5.75 milliunits/L, with a mean value of 1.71 milliunits/L, and predicted that 91.4% of undetectable serum thyrotropin values will fall within the normal range.
The following articles in journals at HighWire Press have cited this article:
![]() |
J. W. Chu and L. M. Crapo The Treatment of Subclinical Hypothyroidism Is Seldom Necessary J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4591 - 4599. [Full Text] [PDF] |
||||
![]() |
J. E. Oesterling Age-Specific Reference Ranges for Prostate-Specific Antigen-Reply JAMA, March 9, 1994; 271(10): 747 - 747. [Abstract] [PDF] |
||||
![]() |
J. V. HENNESSEY, J. E. EVAUL, Y.-C. TSENG, K. D. BURMAN, and L. WARTOFSKY L-Thyroxine Dosage: A Reevaluation of Therapy with Contemporary Preparations Ann Intern Med, July 1, 1986; 105(1): 11 - 15. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |